ENTO
Price:
$2.32
Market Cap:
$11.06M
First Wave BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its product candidates include latiglutenase, a targeted oral biotherapeutic for celiac disease designed to breakdown gluten into non-immunogenic peptides; biologic adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients; capeserod, a selective 5-HT4 receptor partial agonist to treat gastroparesis; and niclosamide, an oral small molecule with anti-inflammatory properties for patients with inflammatory bowel diseases, such as ulcerative co...[Read more]
Industry
Biotechnology
IPO Date
2016-10-11
Stock Exchange
NASDAQ
Ticker
ENTO
According to Entero Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of -100.00% compared to the average of 0.99% of the last 4 quarters.
The mean historical Dividend Yield of Entero Therapeutics, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), ENTO's Dividend Yield was at its highest in in the June 2025 quarter at 2.86%. The Dividend Yield was at its lowest in in the December 2015 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of Entero Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
| Year | Dividend Yield | Change |
|---|---|---|
| 2024 | 0% | 0% |
| 2023 | 0% | 0% |
| 2022 | 0% | 0% |
| 2021 | 0% | 0% |
| 2020 | 0% | 0% |
| 2019 | 0% | 0% |
| 2018 | 0% | 0% |
| 2017 | 0% | 0% |
| 2016 | 0% | 0% |
| 2015 | 0% | 0% |
The current Dividend Yield of Entero Therapeutics, Inc. (ENTO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
Entero Therapeutics, Inc.’s Dividend Yield is less than Curis, Inc. (0%), less than Processa Pharmaceuticals, Inc. (0%), less than BriaCell Therapeutics Corp. (0%), less than Palisade Bio, Inc. (0%), less than Citius Pharmaceuticals, Inc. (0%), less than Leap Therapeutics, Inc. (0%), less than Aspire Biopharma Holdings, Inc. (0%), less than Athira Pharma, Inc. (0%), less than Cingulate Inc. (0%), less than Allarity Therapeutics, Inc. (0%),
| Company | Dividend Yield | Market cap |
|---|---|---|
| 0% | $17.45M | |
| 0% | $15.36M | |
| 0% | $23.06M | |
| 0% | $268.21M | |
| 0% | $13.97M | |
| 0% | $52.15M | |
| 0% | $4.56M | |
| 0% | $15.36M | |
| 0% | $22.09M | |
| 0% | $16.85M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Entero Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Entero Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Entero Therapeutics, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for Entero Therapeutics, Inc. (ENTO)?
What is the highest Dividend Yield for Entero Therapeutics, Inc. (ENTO)?
What is the 3-year average Dividend Yield for Entero Therapeutics, Inc. (ENTO)?
What is the 5-year average Dividend Yield for Entero Therapeutics, Inc. (ENTO)?
How does the current Dividend Yield for Entero Therapeutics, Inc. (ENTO) compare to its historical average?